Published in Blood Weekly, November 11th, 2004
Researchers in the United States conducted a study "to investigate the effects of antifactor D monoclonal antibody (mAb) 166-32 on platelet activation during and after" hypothermic CPB "in baboons."
"Fourteen baboons (mean weight, 15 kg) underwent hypothermic CPB. Seven of them were treated with a single injection of antifactor D mAb 166-32 (5 mg/kg) and the other seven animals were given saline as control," explained A. Undar and coauthors at Penn State University.
"Each baboon was sedated with an intramuscular injection...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.